Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solithromycin crossover study in chronic obstructive pulmonary disease
2014-003077-42Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Jul 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of solithromycin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Imperial College London. Primary endpoint: Change in sputum neutrophils per mL. Started Jul 2015; status: terminated.
02
Drugs
solithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-003077-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003077-42.